Development of a dual inhibitor of pan-RAF and VEGFR2 for the treatment of metastatic colorectal cancer with mutant K-RAS

被引：0
|
作者：
Hong, Sungpyo
Choi, Young-Il
Choi, Jihye
Kim, Wonyoung
Kwon, Ho-Seok
Park, Yong Bin
Ki, Min-Hyo
Shin, Hee Jong
Lee, Michael
Ahn, Soon Kil
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-3782
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3782
引用
收藏
页数：4
相关论文
共 50 条
  • [41] RAF265, a dual BRAF and VEGFR2 inhibitor, prevents osteoclast formation and resorption. Therapeutic implications
    Antonio Garcia-Gomez
    Enrique M. Ocio
    Atanasio Pandiella
    Jesús F. San Miguel
    Mercedes Garayoa
    Investigational New Drugs, 2013, 31 : 200 - 205
  • [42] CLINICAL OUTCOMES IN METASTATIC COLORECTAL CANCER PATIENTS TREATED WITH BEVACIZUMAB AND K-RAS MUTATION STATUS
    Luis, I. V.
    Ribeiro, J.
    Matias, M.
    Casanova, M.
    Semedo, M.
    Pereira, S.
    Miltenberger-Miltenyi, G.
    Castro, A.
    Costa, L.
    ANNALS OF ONCOLOGY, 2010, 21 : 218 - 218
  • [43] Prognostic Significance of Systemic Inflammation Indices by K-ras Status in Patients With Metastatic Colorectal Cancer
    Miyamoto, Yuji
    Akiyama, Takahiko
    Kato, Rikako
    Sawayama, Hiroshi
    Ogawa, Katsuhiro
    Yoshida, Naoya
    Baba, Hideo
    DISEASES OF THE COLON & RECTUM, 2023, 66 (08) : E809 - E817
  • [44] COST-EFFECTIVENESS ANALYSIS OF K-RAS TESTING AND CETUXIMAB FOR METASTATIC COLORECTAL CANCER IN JAPAN
    Shiroiwa, T.
    Motoo, Y.
    Tsutani, K.
    VALUE IN HEALTH, 2010, 13 (07) : A513 - A513
  • [45] Involvement of K-RAS mutations and amino acid substitutions in the survival of metastatic colorectal cancer patients
    Perez-Ruiz, Elisabeth
    Rueda, A.
    Pereda, T.
    Alcaide, J.
    Bautista, D.
    Rivas-Ruiz, F.
    Villatoro, R.
    Perez, D.
    Redondo, M.
    TUMOR BIOLOGY, 2012, 33 (06) : 1829 - 1835
  • [46] Involvement of K-RAS mutations and amino acid substitutions in the survival of metastatic colorectal cancer patients
    Perez-Ruiz, Elisabeth
    Alcaide, Julia
    Pereda, Teresa
    Bautista, Dolores
    Rivas Ruiz, Francisco
    Villatoro, R.
    Redondo, Maximino
    Perez, Diego
    Rueda, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] K-RAS and B-RAF mutation detection in routine diagnostic analysis of colorectal cancer in the Greek population
    Saetta, A.
    Stamatelli, A.
    Palliou, E.
    Tserga, A.
    Tsiorva, P.
    Levidou, G.
    Stratigoula, S.
    Penelope, K.
    Kavantzas, N.
    Michalopoulos, N. V.
    Patsouris, E.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 227 - 227
  • [48] HYPOTHYROIDISM AS A POTENTIAL BIOMARKER OF EFFICACY OF FAMITINIB, A NOVEL VEGFR2 INHIBITOR IN METASTATIC BREAST CANCER
    Cao, J.
    Zhang, J.
    Wang, Z. H.
    Wang, B. Y.
    Lv, F. F.
    Wang, L. P.
    Hu, X. C.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E1 - E1
  • [49] Discovery of a novel pan-RAF inhibitor with potent anti-tumor activity in preclinical models of BRAFV600E mutant cancer
    Hong, Sung Pyo
    Ahn, Soon Kil
    LIFE SCIENCES, 2017, 183 : 37 - 44
  • [50] Concurrent mutation in exons 1 and 2 of the K-ras oncogene in colorectal cancer
    Palmirotta, Raffaele
    Savonarola, Annalisa
    Ludovici, Giorgia
    De Marchis, Maria Laura
    Covello, Renato
    Ettorre, Giuseppe Maria
    Ialongo, Cristiano
    Guadagni, Fiorella
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2011, 49 (04) : 729 - 733
12345